Navigation Links
Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
Date:11/6/2008

SEATTLE, Nov. 6 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today will present a summary of Phase 1 clinical data of NEUVENGE(TM) (lapuleucel-T), an investigational active cellular immunotherapy, at the Chemotherapy Foundation Symposium in New York City. The presentation, which integrates the data from two clinical trials, highlights the safety profile, immune response and clinical activity of NEUVENGE in patients with HER2/neu-positive cancer who have failed standard therapy.

"We are encouraged by the significant immune responses generated to NEUVENGE in these trials, which included patients with advanced breast, ovarian and colon cancer," said John W. Park, M.D., associate clinical professor of medicine and neurosurgery at the University of California, San Francisco. "The therapy was well tolerated and demonstrated evidence of clinical activity, with several patients experiencing prolonged periods of disease stabilization following treatment. These findings warrant further study of this promising immunotherapy."

The two Phase 1 studies (D2000-1 and D2000-2) were designed to evaluate the safety and immunologic activity of NEUVENGE in patients with metastatic HER2/neu-expressing cancer who had evidence of progressive disease following standard therapies. Patients underwent three infusions of NEUVENGE over an approximately one month period. Patients who achieved a partial response, or had stable disease lasting through Week 48, were eligible for re-treatment with a booster, using the same protocol and dose as the initial treatment.

A total of 37 patients were treated. Results from the integrated analysis showed that treatment with NEUVENGE was generally well tolerated. The majority of side effects were mild, including infusion-related fatigue, fever and chills. The median T cell proliferative stimulation index in response to the immunizing antigen increased from 1.3 at baseline to 19.7 at Week 4 (p = 0.0002), 19.4 at Week
'/>"/>

SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
3. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
4. Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
5. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
6. Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
7. Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
8. Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
9. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
10. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...all/ -- Virtual Health Technologies, Inc. (OTC Bul...usly confirmed Letter of Intent to sell all health...ies, Inc (WNDM) is subject to final approval of t...,, Shareholder Assurances ,, "We believe t...nd cash realized from the transaction would benefi...
(Date:11/6/2009)...-- Ardea Biosciences, Inc. (Nasdaq: RDEA ), a bio...mall-molecule therapeutics for the treatment of go... today reported recent accomplishments and financi...nded September 30, 2009. ,, (Logo: http://ww..., "Since our last quarterly update, we have conf...
(Date:11/6/2009)... Cyberonics, Inc. (Nasdaq: CYBX ) today announced...r the second quarter ended October 23, 2009 of its...ovember 18, 2009 at 5:00 PM EST. The company will...s on Thursday, November 19, 2009 at 9:00 AM EST. ,...ference Call Instructions ,, To listen to the...
Breaking Medicine Technology:OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 2OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 3OTCBB-VHGI Updates Shareholders on Status of Healthcare Asset Sale and Treasure Gulch Gold Mine Development Strategy 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Frost 26 Sullivan Recognizes Singulex for Erenna 28R 29 Immunoassay System 48854 1Frost 26 Sullivan Recognizes Singulex for Erenna 28R 29 Immunoassay System 48854 2Frost 26 Sullivan Recognizes Singulex for Erenna 28R 29 Immunoassay System 48854 3Frost 26 Sullivan Recognizes Singulex for Erenna 28R 29 Immunoassay System 48854 4New York State Department of Transportation and American Lung Association in New York Announce Commit to Cleaner Air Week 48851 1New York State Department of Transportation and American Lung Association in New York Announce Commit to Cleaner Air Week 48851 2New York State Department of Transportation and American Lung Association in New York Announce Commit to Cleaner Air Week 48851 3NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai Taiwan and Other Targeted China 12613 1NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai Taiwan and Other Targeted China 12613 2NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai Taiwan and Other Targeted China 12613 3NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai Taiwan and Other Targeted China 12613 4
(Date:11/8/2009)...quot;Preventing and Healing AIDS Through Our Inner...AIDS is a result of multiple, repeated and chronic...stressor agents, which can be either chemical, phy... Oakland, CA (PRWEB) Novem...iologists, physicians, chemists and other scientis...
(Date:11/8/2009)...wire/ -- Today, the House of Representatives passe...lsworth and Lipinski amendment to the "Affordable ...dment maintains the current policy of preventing f...ges that include abortion. It clarifies that indiv...ts and those who do not, can with their own funds ...
(Date:11/8/2009)... to Secure the Stability of Medicare ,, HOUSTO...ributable to: J. James Rohack, M.D., President, Am...www.newscom.com/cgi-bin/prnh/20081209/AMALOGO ) ...th reform bill, which will help improve the health...swift passage of H.R. 3961 to secure the stability...
(Date:11/8/2009)...-USNewswire/ -- March of Dimes hosted the Fourth A...prominent individuals who are celebrating the birt...rch of Dimes commitment to improve the health of b...maturity Awareness Month campaign, celebrities and...reemies! ,, (Photo: http://www.newscom.com/cg...
(Date:11/7/2009)...Cook (GA), Louis J. Goodman (TX), Palmer P. Jones ... Nov. 7 The American Me...al society executive leaders with achievement awar...deals of the medical profession. The awards were p...eting in Houston. ,, (Logo: http://www.newsc...
Breaking Medicine News(10 mins):Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:AMA Honors Medical Society Executives 2
...ng in mice might explain progression from skin to ...ealthDay News) -- A substance secreted by eczema-d... researchers suggest. , The theory comes from a st...sthma. , An estimated 50 percent to 70 percent of ...
... DIEGO, May 19 /PRNewswire/ -- Cylene Pharmace...t major advances in the development of their first...nternational Convention on Wednesday, May 20th at ...mpany,s oral protein kinase inhibitor currently in...
...T CHICAGO, Ill., May 19 Potty Training is a daunt... Registered Pediatric Nurse and Neonatal Specialis...r 650 children in her private practice during the ...The Today Show, or any one of the CBS, NBC or ABC ...
...Can See Clearly Now" Helps Readers Seek Deeper Mea...UISVILLE, Colo., May 19 Mary Soliel,s debut non-f...Illuminates Our Lives," was chosen as an "Indie" F...A Book News as a Finalist in both "Best New Non-Fi...
...wing Urgent Care Center Network Has 6 Front Range ...oration (CSC), the leader in Colorado Practice Man...cured an agreement to be the regional provider of ... , , "This is a key new contract for us," said, P...
...cially designed microsite (www.meettheburns.com) t...ents. , , KENILWORTH, N.J., May 19 Schering-...the arrival of TINACTIN(R) CHILL, an antifungal sp...://www.newscom.com/cgi-bin/prnh/20090519/NY19030 ...
Other Medicine News:Health News:Molecule in Skin May Link Eczema and Asthma 2Health News:Cylene to Announce New Data on Its First-in-Class Oral CK2 Inhibitor Against Cancer at BIO Conference 2Health News:Booty Camp(R) Potty Training Program as Featured in People Magazine is Launched on DVD 2Health News:Author Mary Soliel Receives Third National Book Award for Debut Non-Fiction on Synchronicity 2Health News:Author Mary Soliel Receives Third National Book Award for Debut Non-Fiction on Synchronicity 3Health News:Clinic Service Announces Agreement to Provide Billing Service to MedExpress 2Health News:Video: Schering-Plough Introduces TINACTIN(R) CHILL, a Line of Antifungal Products Geared Specifically to Young Males 2
Dodick-Kammann Nucleus Chopper
Chang Phaco Chopper
Denman Brown Nucleus Cracker
Forceps Epilation Angled End B510.10 3.5"
Medicine Products: